RESISTANT HYPERTENSION
Clinical trials for RESISTANT HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new RESISTANT HYPERTENSION trials appear
Sign up with your email to follow new studies for RESISTANT HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common gout pill help black Veterans' hearts?
Disease control Recruiting nowThis study is testing if Allopurinol, a medication usually used for gout, can improve heart function, exercise ability, and quality of life in African American Veterans with resistant high blood pressure. Researchers will give the drug for 8 weeks to 50 participants to see if it …
Matched conditions: RESISTANT HYPERTENSION
Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Kidney nerve zap: can it tame stubborn high blood pressure for years?
Disease control Recruiting nowThis study is watching 500 people in China who have already had a procedure to calm the nerves in their kidneys to treat resistant high blood pressure. The goal is to see how safe and effective the treatment is over three years, and if it helps lower blood pressure long-term. Res…
Matched conditions: RESISTANT HYPERTENSION
Sponsor: Medtronic Vascular • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Surgeons test new 'Wrap-Around' technique to tame stubborn hypertension
Disease control Recruiting nowThis early study is testing the safety and initial design of a new surgical device called the HyperQure RDN System. It aims to help adults with resistant high blood pressure that isn't controlled by three or more medications. Doctors will perform a laparoscopic surgery to wrap th…
Matched conditions: RESISTANT HYPERTENSION
Phase: NA • Sponsor: DeepQure Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
First-in-Human trial tests new surgery for untamable high blood pressure
Disease control Recruiting nowThis is the first study in people to test the safety and early effectiveness of a new surgical procedure called HyperQure. The procedure aims to lower blood pressure in patients whose high blood pressure is not controlled despite taking three or more medications. Doctors will per…
Matched conditions: RESISTANT HYPERTENSION
Phase: NA • Sponsor: DeepQure Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Zap and squeeze: could this combo tame stubborn high blood pressure?
Disease control Recruiting nowThis study is testing if a combination of gentle electrical skin stimulation and handgrip exercises can help lower blood pressure in people whose high blood pressure isn't controlled by multiple medications. It will involve 50 men and women aged 50-60. Researchers will compare th…
Matched conditions: RESISTANT HYPERTENSION
Phase: NA • Sponsor: Mohamed Mohamed Ali Morgan • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Hope for stubborn hypertension: trial tests new drug to protect blood vessels
Disease control Recruiting nowThis study is testing if adding a new type of drug (an endothelin receptor blocker) can improve blood vessel health and help control blood pressure in people whose high blood pressure remains high despite taking three medications. Researchers will measure how well blood vessels r…
Matched conditions: RESISTANT HYPERTENSION
Phase: PHASE2 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Stiff arteries could reveal Who's really taking their blood pressure pills
Knowledge-focused Recruiting nowThis study aims to see if measuring how stiff a person's arteries are can help doctors figure out if patients with resistant high blood pressure are actually taking their prescribed medications. Researchers will enroll 60 adults with this hard-to-control condition. They will use …
Matched conditions: RESISTANT HYPERTENSION
Phase: NA • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC